An Italian consensus for invasive candidiasis management (ITALIC)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Infection

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s15010-013-0558-0PMID 24272916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

  2013influential reference
• Quality of evidence

  2013cited by this paper
• (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.

  2012cited by this paper
• Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

  2012cited by this paper
• β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

  2012cited by this paper
• Diagnosis, management and outcome of Candida endocarditis.

  2012cited by this paper
• Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection

  2012cited by this paper
• Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia

  2012cited by this paper
• Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit

  2012cited by this paper
• Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia

  2012cited by this paper
• Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

  2012cited by this paper
• Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.

  2012cited by this paper
• Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature.

  2012cited by this paper
• Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

  2012influential reference
• Septic shock attributed to Candida infection: importance of empiric therapy and source control.

  2012cited by this paper
• Newer Systemic Antifungal Agents

  2012cited by this paper
• Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

  2012cited by this paper
• Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units.

  2012cited by this paper
• Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• Voriconazole in clinical practice

  2012cited by this paper
• Candida spp. with Acquired Echinocandin Resistance, France, 2004–2010

  2012cited by this paper
• In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.

  2012cited by this paper
• Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients

  2012cited by this paper
• Clinical characteristics and risk factors of ocular candidiasis.

  2012cited by this paper
• Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia

  2012cited by this paper
• β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

  2011cited by this paper
• Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin‐lock therapy

  2011cited by this paper
• Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy

  2011cited by this paper
• Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review

  2011cited by this paper
• Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index

  2011cited by this paper
• Ocular manifestations of candidemia.

  2011cited by this paper
• Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France

  2011cited by this paper
• Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease

  2011cited by this paper
• Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature

  2011cited by this paper
• Value of (1-3)-β-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia.

  2011cited by this paper
• Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.

  2011cited by this paper
• Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.

  2011cited by this paper
• European expert opinion on the management of invasive candidiasis in adults.

  2011cited by this paper
• Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study

  2011cited by this paper
• Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

  2011cited by this paper
• Candida urinary tract infections--treatment.

  2011cited by this paper
• Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis

  2011cited by this paper
• Current issues in the clinical management of invasive candida infections – the AGIHO, DMykG, ÖGMM and PEG web‐based survey and expert consensus conference 2009

  2011cited by this paper
• Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

  2011cited by this paper
• Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

  2011cited by this paper
• Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?

  2011cited by this paper
• Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul‐Ehrlich‐Society for Chemotherapy

  2011cited by this paper
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

  2011influential reference
• Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia

  2011cited by this paper
• A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.

  2011cited by this paper
• Diagnosing invasive fungal disease in critically ill patients

  2011cited by this paper
• The Effect of Cumulative Length of Hospital Stay on the Antifungal Resistance of Candida Strains Isolated from Critically Ill Surgical Patients

  2010cited by this paper
• PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis

  2010cited by this paper
• The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

  2010influential reference
• Detection of candidaemia in patients with and without underlying haematological disease.

  2010cited by this paper
• Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

  2010cited by this paper
• Prophylaxis, empirical and preemptive treatment of invasive candidiasis

  2010cited by this paper
• A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.

  2010cited by this paper
• Prospective Survey of (1→3)-β-d-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

  2010cited by this paper
• Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

  2010cited by this paper
• Early antifungal intervention strategies in ICU patients

  2010cited by this paper
• A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

  2009cited by this paper
• Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.

  2009cited by this paper
• Antifungal drug resistance: do molecular methods provide a way forward?

  2009cited by this paper
• Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

  2009influential reference
• Effect of Antifungal Therapy Timing on Mortality in Cancer Patients with Candidemia

  2009cited by this paper
• Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

  2009cited by this paper
• Case for a pharmacy-centered medical home.

  2009cited by this paper
• Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit

  2009cited by this paper
• Candida Infective Endocarditis: Report of 15 Cases From a Prospective Multicenter Study

  2009cited by this paper
• Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis?

  2009cited by this paper
• Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

  2009cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009influential reference
• Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

  2009cited by this paper
• Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study

  2009cited by this paper
• Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever.

  2009cited by this paper
• Towards molecular diagnostics of invasive fungal infections

  2009cited by this paper
• Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

  2009cited by this paper
• Making trials matter: pragmatic and explanatory trials and the problem of applicability

  2009cited by this paper
• Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

  2009cited by this paper
• Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.

  2009cited by this paper
• Treatment of invasive candidal infections: systematic review and meta-analysis.

  2008cited by this paper
• Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.

  2008cited by this paper
• Time to Blood Culture Positivity as a Marker for Catheter-Related Candidemia

  2008cited by this paper
• A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults.

  2008cited by this paper
• Going from evidence to recommendations

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies

  2008cited by this paper
• Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

  2008cited by this paper
• Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.

  2008cited by this paper
• Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive

  2008cited by this paper
• Ocular candidiasis: a review

  2008cited by this paper
• Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.

  2008cited by this paper
• Contribution of serum biomarkers to the diagnosis of invasive candidiasis

  2008cited by this paper
• What is “quality of evidence” and why is it important to clinicians?

  2008cited by this paper
• Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

  2008cited by this paper
• Empirical Fluconazole versus Placebo for Intensive Care Unit Patients

  2008cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007influential reference
• Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

  2007cited by this paper

• Antifungal Policy and Practice Across Five Countries: A Qualitative Review

  2025cites this paper
• Critical appraisal beyond clinical guidelines for intraabdominal candidiasis

  2023cites this paper
• Prescribing patterns of echinocandins in adult patients in a private hospital in Gauteng, South Africa

  2023influential citation
• The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards

  2022cites this paper
• Tratamiento antifúngico individualizado en el paciente crítico con infección fúngica invasora Individualized antifungal therapy in critically ill patients with invasive fungal infection

  2021cites this paper
• Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis

  2021cites this paper
• [Individualized antifungal therapy in critically ill patients with invasive fungal infection].

  2021cites this paper
• Candidemia en Colombia

  2020cites this paper
• Liposomal Amphotericin B and Flucytosine Versus Micafungin in Treatment of Candida Endocarditis

  2020influential citation
• Clinical characteristics, management and outcome of patients with invasive candidiasis hospitalized in Internal Medicine Units: findings from a registry by the Italian Scientific Society FADOI

  2020cites this paper
• Quantification of 1,3‐β‐d‐glucan by Wako β‐glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study

  2020cites this paper
• A proposal for a comprehensive approach to infections across the surgical pathway

  2020cites this paper
• What´s new in intraabdominal candidiasis in critically ill patients, a review

  2019cites this paper
• Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials.

  2019cites this paper
• ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

  2019cites this paper
• Diagnosis and Treatment of Candidemia in the Intensive Care Unit

  2019cites this paper
• Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?

  2019influential citation
• Criteria for the administration of systemic antimicotic therapy in surgical intensive care units (literature review)

  2019cites this paper
• Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.

  2018cites this paper
• Untargeted Antifungal Treatment in the ICU: Changing Definitions and Labels Do Not Change the Evidence.

  2018cites this paper
• Management of patients with septic shock due to Candida infection

  2018cites this paper
• A study on rapid diagnosis (by PCR) and cost-effective treatment of pulmonary mycosis

  2018cites this paper
• Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients

  2018cites this paper
• Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study

  2018cites this paper
• Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

  2018cites this paper
• The prescribing practices of echinocandins in adult patients in a private hospital

  2018cites this paper
• The Effect of Use of Anidulafungin on Failure of Weaning Due to Ventilator-associated Pneumonia which Complicate Contused Lungs

  2018cites this paper
• Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period

  2018cites this paper
• The authors reply.

  2018cites this paper
• What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead

  2018cites this paper
• Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials

  2017cites this paper
• Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis.

  2017cites this paper
• Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?

  2017cites this paper
• MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management.

  2016cites this paper
• Initial antifungal strategy does not correlate with mortality in patients with candidemia

  2016cites this paper
• The current treatment landscape: candidiasis.

  2016cites this paper
• Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors

  2016cites this paper
• Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-d-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure

  2016influential citation
• Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy.

  2016cites this paper
• Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study

  2016cites this paper
• Invasive Candida Infections in the ICU: Diagnosis and Therapy

  2015cites this paper
• The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards

  2015cites this paper
• Correction: The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards

  2015cites this paper
• Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?

  2015cites this paper
• Evaluation of CHROMagar Candida , VITEK 2 YST and VITEK ® MS for identification of Candida strains isolated from blood cultures

  2015cites this paper
• Intensive Care Units: at the Frontline of Infectious Disease

  2014cites this paper
• Appropriateness and cost-effectiveness in the treatment of invasive candidiasis in Internal Medicine Wards

  2014cites this paper